Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression

Experimental Hematology

Volumn 28, Issue 6, 2000, Pages 612-625

  Rutella, Sergio ^a   Rumi, Carlo ^a   Pierelli, Luca ^a   Morosetti, Roberta ^a   Sica, Simona ^a   Bonanno, Giuseppina ^a   Scambia, Giovanni ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cell cycle progression; G CSF; Mitochondria

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN BAX; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; MITOCHONDRION; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD PHYSIOLOGY; CELL CYCLE; CELLS, CULTURED; DEPRESSION, CHEMICAL; DNA FRAGMENTATION; FEMALE; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MITOCHONDRIA; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS;

EID: 0034086855     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00164-8     Document Type: Article

References (53)

1. Sica S., Rutella S., Di Mario A.et al. RhG-CSF in healthy donors. mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes J Hematother. 5:1996;391.
2. Pierelli L., Menichella G., Scambia G.et al. Growth factor administration following autologous peripheral blood progenitor cell transplantation. Leuk Lymphoma. 27:1997;65.
3. Bensinger W.I., Clift R., Martin P.et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies. a retrospective comparison with marrow transplantation Blood. 88:1996;2794.
4. Russell J.A., Brown C., Bowen T.et al. Allogeneic blood cell transplants for hematological malignancy. preliminary comparison of outcomes with bone marrow transplantation Bone Marrow Transplant. 17:1996;703.
5. Schmitz N., Bacigalupo A., Labopin M.et al. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Baematol. 95:1996;715.
6. Solano C., Martinez C., Brunet S.et al. Chronic graft-vs-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Bone Marrow Transplant. 22:1998;1129.
7. Vigorito A.C., Azevedo W.M., Marques J.F.C.et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant. 22:1998;1145.
8. Blaise D., Jourdan E., Michallet M.et al. Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies. a pilot study Bone Marrow Transplant. 22:1988;1153.
9. Pan L., Delmonte J., Jalonen C.K., Ferrara J.L.M. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-vs-host disease. Blood. 86:1995;4422.
10. Zeng D., Dejbakhsh-Jones S., Strobert S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-vs-host disease. impact on blood progenitor cell transplantation Blood. 90:1997;453.
11. Pan L., Teshima T., Hill G.R.et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-vs-leukemia effects through a perforin-dependent pathway while preventing graft-vs-host disease. Blood. 93:1999;4071.
12. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood. 8:1997;1629.
13. Ino K., Singh R.K., Talmadge J.E. Monocytes from mobilized stem cells inhibit T cell function. J Leuk Biol. 61:1997;583.
14. Rutella S., Rumi C., Testa U.et al. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF). possible role of lactoferrin and interleukin-1 receptor antagonist Bone Marrow Transplant. 20:1997;355.
15. Rutella S., Rumi C., Lucia M.B., Sica S., Testa U., Leone G. Humoral mediated suppression of lymphocyte blastogenesis in healthy donors receiving rhG-CSF. Eur J Histochem. 41:1997;51.
16. Rutella S., Rumi C., Lucia M.B., Sica S., Cauda R., Leone G. Serum of healthy donors receiving granulocyte colony-stimulating factor induces T-cell unresponsiveness. Exp Hematol. 26:1998;1024.
17. Zamzami N., Marchetti P., Castedo M.et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 182:1995;367.
18. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309.
19. Castedo M., Macho A., Zamzami N.et al. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur J Immunol. 25:1995;3277.
20. Marchetti P., Castedo M., Susin S.A.et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 184:1996;1155.
21. Marchetti P., Susin S.A., De Caudin D.et al. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 56:1996;2033.
22. Gore S.D., Weng L., Burke P.J. Validation of flow cytometric determination of Ki67 expression as a measure of growth factor response in acute myelogenous leukemia. Exp Hematol. 21:1993;1702.
23. + cells in the absence of other growth factors. Exp Hematol. 23:1995;413.
24. Morosetti R., Kawamata N., Gombart A.F.et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphoma and adult T-cell leukemia-lymphoma. Blood. 86:1995;1924.
25. McGuinness D., Bennett S., Riley E. Statistical analysis of highly skewed immune response data. J Immunol Methods. 201:1997;99.
26. Przepiorka D., Smith T.L., Follder J.et al. Risk factors for acute graft-vs-host disease after allogeneic blood stem cell transplantation. Blood. 94:1999;1465.
27. Rutella S., Rumi C., Sica S., Leone G. Recombinant human granulocyte colony-stimulating factor (rhG-CSF). effects on lymphocyte phenotype and function J Interf Cytok Res. 19:1999;989.
28. Hartung T. Immunomodulation by colony-stimulating factors. Rev Physiol Biochem Pharmacol. 136:1999;1.
29. Mellstedt H., Fagerberg J., Frodin J.E.et al. Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors. Curr Opin Hematol. 6:1999;169.
30. Sloan-Lancaster J., Evavold B.D., Allen P.M. Th2 cell clonal anergy as a consequence of partial activation. J Exp Med. 190:1994;1195.
31. Ageitos A.G., Varney M.L., Bierman P.J., Vose J.M., Warkentin P.I., Talmadge J.E. Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilised PSC products. Bone Marrow Transplant. 23:1999;63.
32. Singh R.K., Ino K., Varney M.L., Heimann D.G., Talmadge J.E. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products. Bone Marrow Transplant. 23:1999;53.
33. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis. doubt no more Biochim Biophys Acta. 1336:1998;151.
34. Lemaasters J.J., Nieminen A., Quian T.et al. The mitochondrial permeability transition in cell death. a common mechanism in necrosis, apoptosis and autophagy Biochim Biophys Acta. 1366:1998;177.
35. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differentiation. 6:1999;99.
36. Verhoven B., Krahling S., Schlegel S., Williamson P. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differentiation. 6:1999;99.
37. Minn A.F., Swain R.E., Ma A., Thompson C.B. Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv Immunol. 70:1998;245.
38. Richter C., Schweizer M., Cossarizza A., Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett. 378:1996;107.
39. Cossarizza A., Mussini C., Mongiardo N.et al. Mitochondrial alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS. 11:1997;19.
40. Cai J., Jones D.P. Superoxide in apoptosis. J Biol Chem. 273:1998;11401.
41. Saito T. Negative regulation of T cell activation. Curr Opin Immunol. 10:1998;313.
42. Hartung T., Docke W.D., Gantner F.et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunters. Blood. 85:1995;2482.
43. Hoffman B., Liebermann D.A. The pro-oncogene c-myc and apoptosis. Oncogene. 17:1998;3351.
44. Veis D.J., Sentman C.L., Bach E.A., Korsmeyer S.J. Expression of the blc-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol. 151:1993;2546.
45. Wickremasinghe R.G., Hoffbrand A.V. Biochemical and genetic control of apoptosis. relevance to normal hematopoiesis and hematological malignancies Blood. 93:1999;3587.
46. Montani M.S., Tuosto L., Giliberti R., Stefanini L., Cundari E., Piccolella E. Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2. Cell Death Differentiation. 6:1999;79.
47. Adams J.M., Cory S. The blc-2 protein family:arbiters of cell survival. Science. 281:1998;1322.
48. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317.
49. Zamzami N., Marchetti P., Castedo M.et al. Reduction of mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 181:1995;1661.
50. Pastorino J.G., Tafani M., Rothman R.J., Marcineviciute A., Hoek J.B., Farber J.L. Functional consequences of the sustained or transient activation of the mitochondrial permeability transition pore. J Biol Chem. 274:1999;31734.
51. Scaffidi C., Fulda S., Srinivasan A.et al. Two CD95 (APO-1/Fas)-signaling pathways. EMBO J. 17:1998;1675.
52. Peter M.E., Krammer P.H. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol. 10:1998;545.
53. Murphy K.M., Streips U.N., Lock R.B. Bax membrane insertion during FAS(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene. 18:1999;5991.